Diff Profiles › MTBLS6402_0002_00000001

Control_Vehicle_vs_FSCN1_Knockout_Vehicle

Control_Vehicle vs FSCN1_Knockout_Vehicle

p-value ≤ 0.05 28 significant 2025-09-26 00:00:00 Study: MTBLS6402
102 Total Features
28 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS6402_0002_00000001
Linked study
MTBLS6402 — FSCN1 as a new druggable target in adrenocortical carcinoma
Comparison
Control_Vehicle vs FSCN1_Knockout_Vehicle
Group A
Control group treated with vehicle. Provides baseline for comparison with FSCN1 knockout under vehicle treatment
Group B
FSCN1 knockout group treated with vehicle. Allows assessment of FSCN1 knockout effects compared to control under vehicle treatment
Total features tested
102
Significant features
28
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
OPVPGKGADVGKTG-BQBZGAKWSA-N N-Acetyl-1-aspartylglutamic acid up 406.1 1.08e-05
YPZRWBKMTBYPTK-BJDJZHNGSA-N OXIDIZED GLUTATHIONE DISULFIDE up 372.2 0.0044
RNVCVTLRINQCPJ-UHFFFAOYSA-N 2-Aminotoluene up 10.89 1.05e-05
DFPAKSUCGFBDDF-UHFFFAOYSA-N β-pyridinecarboxamide down 0.1186 8.49e-06
LRQKBLKVPFOOQJ-YFKPBYRVSA-N α-aminocaproic acid up 76.19 0.004
WRFPVMFCRNYQNR-UHFFFAOYSA-N 2-amino-3-(2-hydroxyphenyl)propanoic acid up 27.78 0.000802
LXNHXLLTXMVWPM-UHFFFAOYSA-N vitamin B<small><sub>6</sub></small> up 13.58 0.000262
BQOHYSXSASDCEA-KEOHHSTQSA-N cADPR up 13.23 0.00127
LOIYMIARKYCTBW-UHFFFAOYSA-N 3-(1<em>H</em>-imidazol-4-yl)-2-propenoic acid up 99.14 0.024
CKLJMWTZIZZHCS-REOHCLBHSA-N L-Aspartic acid up 2.538 0.000227